BCL2 and neoplasm: Bcl-2 inhibitors showed enhanced efficiacy in combination with conventional chemotherapeutic drugs (i.e., paclitaxel, 5-FU, topotecan) but with these combinations still not all of the tumor cells can be reached [23, 24].